International Clinical Trial: Phase 3 Study to Evaluate the Efficacy and Safety of Oral Minoxidil (N1087) in Men With Androgenetic Alopecia

Geneva, April 27 -- International Clinical Trials Registry received information related to the study (NCT07529977) titled 'Phase 3 Study to Evaluate the Efficacy and Safety of Oral Minoxidil (N1087) in Men With Androgenetic Alopecia' on April 8.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Triple (Participant, Care Provider, Investigator).

Primary Sponsor: Eurofarma Laboratorios S.A.

Condition: Androgenetic Alopecia Androgenetic Alopecia (AGA)

Intervention: Drug: Minoxidil oral solution

Recruitment Status: Not recruiting

Phase: Phase 3

Date of First Enrollment: January 31, 2027

Target Sample Size: 372

To know more, visit http...